How will generative AI disrupt data science in drug discovery?
The DOI matches its Crossref record; 23 of the 24 references it cites were found in a registry or an index, and 1 are not checked yet.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Generative AI models are also being used to generate novel small molecules, nucleic acid sequences and proteins with a desired structure or function, thus aiding in drug discovery [11].”
From Generative AI in healthcare: an implementation science informed translational path on application, integration and governance (2024) · cites this paper as [11]
In the citing paper
“By analysing the chemical structure of successful drugs and simulating variations, generative AI can produce potential drug candidates at a much faster rate than traditional drug discovery methods.”
From Generative AI in healthcare: an implementation science informed translational path on application, integration and governance (2024) · cites this paper as [11]
In the citing paper
“By analysing vast amounts of data, generative AI can help to identify potential issues that may arise during clinical trials, which can ultimately reduce the time and cost of drug development [11, 38].”
From Generative AI in healthcare: an implementation science informed translational path on application, integration and governance (2024) · cites this paper as [11]
Citations
Cites
Representation Learning: A Review and New Perspectives
Bengio, Y., Courville, A., & Vincent, P. (2013) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2013.50 · Cited by 13,001
Model Cards for Model Reporting
Mitchell, M., Wu, S., Zaldivar, A., Barnes, P., Vasserman, L., Hutchinson, B., Spitzer, E., Raji, I. D., & Gebru, T. (2019) · Proceedings of the Conference on Fairness, Accountability, and Transparency · doi:10.1145/3287560.3287596 · Cited by 2,681
Robust deep learning–based protein sequence design using ProteinMPNN
Dauparas, J., Anishchenko, I., Bennett, N., Bai, H., Ragotte, R. J., Milles, L. F., Wicky, B. I. M., Courbet, A., de Haas, R. J., Bethel, N., et al. (2022) · Science · doi:10.1126/science.add2187 · Cited by 2,210
Robust deep learning based protein sequence design using ProteinMPNN
Dauparas, J., Anishchenko, I., Bennett, N., Bai, H., Ragotte, R. J., Milles, L. F., Wicky, B. I. M., Courbet, A., de Haas, R. J., Bethel, N., et al. (2022) · doi:10.1101/2022.06.03.494563 · Cited by 2,107
Artificial hallucinations in ChatGPT: implications in scientific writing
Alkaissi, H., & McFarlane, S. I. (2023) · Cureus · doi:10.7759/cureus.35179 · Cited by 1,540
Taxonomy of Risks posed by Language Models
Weidinger, L., Uesato, J., Rauh, M., Griffin, C., Huang, P.-S., Mellor, J., Glaese, A., Cheng, M., Balle, B., Kasirzadeh, A., et al. (2022) · 2022 ACM Conference on Fairness Accountability and Transparency · doi:10.1145/3531146.3533088 · Cited by 764
Galactica: A Large Language Model for Science
Taylor, R., Kardas, M., Cucurull, G., Scialom, T., Hartshorn, A., Saravia, E., Poulton, A., Kerkez, V., & Stojnic, R. (2022) · arXiv · doi:10.48550/arxiv.2211.09085 · Cited by 605
A compact review of molecular property prediction with graph neural networks
Wieder, O., Kohlbacher, S., Kuenemann, M., Garon, A., Ducrot, P., Seidel, T., & Langer, T. (2020) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2020.11.009 · Cited by 522
The debate over understanding in AI’s large language models
Mitchell, M., & Krakauer, D. C. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215907120 · Cited by 340
Generative models for molecular discovery: Recent advances and challenges
Bilodeau, C., Jin, W., Jaakkola, T., Barzilay, R., & Jensen, K. F. (2022) · WIREs Computational Molecular Science · doi:10.1002/wcms.1608 · Cited by 318
Research works printed but not linked: 4
- Brown, T. B. et al. In Adv. Neural Inf. Process. Syst. 33 (eds Larochelle, H. et al.) 1877–1901 (Curran Associates, 2020).
- Baid, G. et al. Nat. Biotechnol. 41, 232–238 (2023).
- Vaswani, A. et al. In Adv. Neural Inf. Process. Syst. 30 (eds Guyon, I. et al.) 6000–6010 (Curran Associates, 2017).
- Alkaissi, H. & McFarlane, S. I. Cureus 15, e35179 (2023).
Cited by
Reddy, S. (2024) · Implementation Science · doi:10.1186/s13012-024-01357-9 · Cited by 554
“Generative AI models are also being used to generate novel small molecules, nucleic acid sequences and proteins with a desired structure or function, thus aiding in drug discovery [11].”
BackgroundMethodBindingDB in 2024: a FAIR knowledgebase of protein-small molecule binding data
Liu, T., Hwang, L., Burley, S. K., Nitsche, C. I., Southan, C., Walters, W. P., & Gilson, M. K. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkae1075 · Cited by 236
“Applications of generative AI methods that propose drug-like ligands ( 35–45 ) frequently assess the quality of their generated ligands in terms of the quantitative estimate of drug-likeness (QED) ( 46 ), on a scale of 0–1.”
A guide to artificial intelligence for cancer researchers
Perez-Lopez, R., Ghaffari Laleh, N., Mahmood, F., & Kather, J. N. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-024-00694-7 · Cited by 211
“Other deep learning models could be trained to generate specific compounds with a desired property, including small molecules 147 , but also RNA or proteins 148 .”
ChatGPT Research Group for Optimizing the Crystallinity of MOFs and COFs
Zheng, Z., Zhang, O., Nguyen, H. L., Rampal, N., Alawadhi, A. H., Rong, Z., Head-Gordon, T., Borgs, C., Chayes, J. T., & Yaghi, O. M. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c01087 · Cited by 172
A GPT‐4 Reticular Chemist for Guiding MOF Discovery**
Zheng, Z., Rong, Z., Rampal, N., Borgs, C., Chayes, J. T., & Yaghi, O. M. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202311983 · Cited by 162
Metadata
- Authors
- Vert, J.-P.
- Corresponding author
- Vert, Jean-Philippe
- ORCID
- Vert, Jean-Philippe
- Venue
- Nature Biotechnology
- Published
- 2023-05-08
- Volume
- 41
- Issue
- 6
- Pages
- 750-751
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W4375861579
- Semantic Scholar
- 808dcba89421d7f926f50ad88f41c42788ac4875
- Cited by
- 73
- References
- 22
- Citations by year
- 2026: 9 · 2025: 22 · 2024: 28 · 2023: 14
- FWCI
- 10.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Keywords
- generative AI, drug discovery, data science, AI disruption, molecular generation
- MeSH terms
- Data Science, Artificial Intelligence, Drug Design, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: How will generative AI disrupt data science in drug discovery? https://app.cochat.ai/papers/10.1038/s41587-023-01789-6
- The paper
- Vert, J.-P. (2023). How will generative AI disrupt data science in drug discovery? Nature Biotechnology. https://doi.org/10.1038/s41587-023-01789-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.